Programs

Enhancing Patient Outcomes in Head and Neck Cancer: Strategies for Managing Mucositis

Mucositis is the major dose-limiting toxicity for patients undergoing intensive chemoradiation therapy for head and neck cancer. Mucositis imposes a substantial clinical and economic burden. Designed for oncologists, radiation oncologists, and nurses, this 1-hour continuing education monograph reviews current strategies for assessing and managing mucositis in patients undergoing treatment for head and neck cancer. Among the topics addressed are the pathobiology of mucositis, scales for grading mucositis severity, clinical assessment tools, and current standards of care as defined in practice guidelines.

This activity is supported by an educational donation provided
by Amgen.

Please contact Continuing Education Alliance at inquiries@cealliance.org for questions regarding this activity.

Release date: May 15, 2007 Expiration: May 15, 2008

This activity has expired. The accredited provider can no longer issue certificates for this activity.


		Physician self-assessment questions and evaluation form are included in the monograph. Nurses may click here to access the self-assessment questions and evaluation form.